Sierra Leone is deploying a range of measures to control and end an outbreak of mpox in which 18 cases have so far been reported since the disease was confirmed on 13 January 2025.
The National Public Health Agency, with support from partners, including World Health Organization (WHO), is stepping up disease surveillance to swiftly detect cases, provide care and prevent further spread of infection. With technical and logistical support from WHO, emergency public health workers are enhancing active case search and investigation for a more effective outbreak response.
Sierra Leone has been reinforcing preparedness and capacity to respond to public health emergencies in recent years. In November 2024, WHO supported the training of 65 health workers and laboratory personnel in diagnostic procedures and sample collection. Additionally, 160 health workers were trained on integrated approach covering surveillance, case management, infection prevention and control, laboratory practices, and risk communication and community engagement. This proactive approach ensured frontline workers were prepared to manage the mpox outbreak from the onset.
To further help curb the spread of the disease, a consignment of 61 300 vaccine doses is expected to be delivered in the coming weeks in Sierra Leone thanks to support from WHO and Gavi, the Vaccine Alliance, Africa Centers for Disease Control and Prevention and UNICEF. These organizations will cover operational costs for the vaccination targeting at-risk people, including health workers. Additionally, efforts, coordinated by partners, including UNICEF, are underway to increase public awareness about the disease as well as encourage preventive measures and the importance of seeking medical care.
WHO has already delivered over US$ 38 000 worth of essential laboratory supplies and personal protective equipment, including gloves, gowns, aprons, face shields, biohazard waste bags, and infrared thermometers. Supplies also included genomics sequencing reagents, PCR kits for 400 tests, GeneXpert cartridges for 50 tests, and genomic sequencing kits for 45 tests.
Clinical care is also being reinforced. WHO has procured treatment kits for 20 inpatients and 180 outpatients and is providing technical expertise to clinicians and other responders by assisting in the planning of response activities and developing case management guidelines and training programmes.
“Despite numerous challenges, WHO has successfully mobilized resources at all levels to deliver vital commodities, including vaccines,” says Dr George Ameh, WHO Representative in Sierra Leone. “We will continue to support the country to bring this current outbreak under control.”
An upsurge of mpox (formerly known as monkeypox) in the Democratic Republic of the Congo and its spread to neighbouring countries was declared a public health emergency of international concern on 14 August 2024. At total of 22 countries in the African region have reported cases since 2024, of which 12 currently have active outbreaks.
WHO and partner organizations are working closely with the affected countries to contain these outbreaks. According to Professor Foday Sahr, the Director of Sierra Leone’s National Public Health Agency, the support by WHO “continues to ensure our ministry and agency succeed in safeguarding the health of our citizens.”
Mpox is a viral disease caused by an orthopoxvirus. It spreads mainly through close contact with someone who has mpox, causing a painful rash, enlarged lymph nodes, and fever. In severe cases, the disease can be deadly.
World Health Organization – Sierra Leone.
OTHER ARTICLES
Fight Against HIV: Africa Moves Toward Self-Sufficiency With Local Production of Treatments
Zambia : The vital role of community health assistants in public health surveillance
Lusaka — African health ministers and partners are calling for increased investment in integrated health services to address the growing burden of severe noncommunicable diseases (NCDs), particularly those affecting women and underserved populations across the region. At a high-level side event during the Seventy-fifth session of the WHO Regional Committee for Africa, delegates emphasized the urgent need for equitable access to prevention, screening, treatment, and rehabilitation across the continuum of care for NCDs. Disparities are especially pronounced in rural areas, where health infrastructure and services remain inadequate. Breast and cervical cancers are among the leading causes of cancer-related deaths among women in sub-Saharan Africa—particularly cervical cancer, which is both preventable and treatable. It remains the most common cause of cancer death for women in the region. In 2022, Africa accounted for nearly a quarter (23%) of the 76 000 global cervical cancer deaths. Meanwhile, severe NCDs such as Type 1 diabetes, sickle cell disease, and heart conditions claim more than half a million lives annually, including among children, adolescents, and young adults in some of the continent’s poorest communities. Inequitable access to health services continues to hinder efforts to reduce this burden. To improve cervical and breast cancer care in the region, urgent investment is needed in leadership, governance, and financing. Strengthening these foundations is critical in the current funding landscape. Advancements in strategic planning, healthcare infrastructure, workforce training, and—most importantly—equitable access to screening, diagnostic, and treatment services are essential. To address these challenges, WHO and its partners showcased successful integrated models such as the Women’s Integrated Care for Cancer Services (WICS), the BEAT Breast Cancer Project, and the PEN-Plus Strategy. WICS strengthens early detection, treatment, and integration of women’s cancer services into primary health care systems in Côte d’Ivoire, Kenya, and Zimbabwe. The BEAT Breast Cancer Project is a transformative multi-year initiative aimed at reducing breast cancer mortality among women in Tanzania and Ghana through early detection, timely diagnosis, and comprehensive treatment access. “PEN-Plus, WICS and the BEAT Breast Cancer Initiative are models for a new standard of care, rooted in equity, access and health justice. I urge countries to prioritize policies that embed these models into broader health system strengthening, said Dr Mohamed Janabi, WHO Regional Director for Africa”. Côte d’Ivoire offers a compelling example of progress, combining high HPV vaccination coverage—reaching over three million girls (91.4%)—with WICS-supported community-based screening campaigns to strengthen cervical cancer prevention. In Kenya, cervical cancer screening has been successfully integrated into national health services. “This gathering marks a pivotal moment to accelerate action for breast cancer prevention in Africa. We deeply value the leadership of the Ministries of Health of Ghana and Tanzania, and the steadfast support of the Pfizer Foundation in helping us achieve this milestone. The side event builds momentum for the policy prioritization of women’s cancers, partnerships to strengthen the broader women’s cancer ecosystem, and advance a health-systems approach to breast cancer prevention and management”, said Dr Somesh Kumar, Senior Director, Jhpiego. PEN-Plus expands access to care for severe NCDs at the district hospital level. Since its implementation, 20 countries in Africa have increased access to services for severe NCDs. Over 15 000 people are currently receiving treatment for chronic conditions such as sickle cell disease and Type 1 diabetes through PEN-Plus clinics.